FDA Grants Breakthrough Device Desnation to MeMed Severity

memedMeMed BV® delivers a breakthrough in rapid diagnostics Our 15-minute test differentiates between bacterial and viral infections, empowering patients, optimizing provider workflows,MeMed Severity aims to aid clinicians in rapid risk stratification and predicting disease progression, in conjunction with clinical assessments and other